Increased IL‐11 signaling has been associated with cancer proliferation, metastasis, and chemoresistance,14, 15, 16, 17, 18 leading to the progression of gastric, colorectal, breast, and bone cancers among others.19, 20, 21, 22. Here, IL11 is linked to cancer.